BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 18411052)

  • 1. Limbic encephalitis - a review.
    Anderson NE; Barber PA
    J Clin Neurosci; 2008 Sep; 15(9):961-71. PubMed ID: 18411052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
    Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
    Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope of autoantibodies to N-methyl-D-aspartate receptor heteromers in paraneoplastic limbic encephalitis.
    Takahashi Y
    Ann Neurol; 2008 Jul; 64(1):110-1; author reply 111-2. PubMed ID: 18350587
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies to glutamate receptor GluRepsilon2 in a patient with limbic encephalitis associated with relapsing polychondritis.
    Kashihara K; Kawada S; Takahashi Y
    J Neurol Sci; 2009 Dec; 287(1-2):275-7. PubMed ID: 19716567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.
    Ohshita T; Kawakami H; Maruyama H; Kohriyama T; Arimura K; Matsumoto M
    J Neurol Sci; 2006 Dec; 250(1-2):167-9. PubMed ID: 17028029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
    Dalmau J; Bataller L
    Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune limbic encephalitis: importance of early diagnosis and treatment].
    van Vliet J; Meulstee J; Hartong EG; Mulleners WM
    Ned Tijdschr Geneeskd; 2012; 156(16):A4455. PubMed ID: 22510418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
    Yamamoto T; Tsuji S
    Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limbic encephalitis and variants: classification, diagnosis and treatment.
    Tüzün E; Dalmau J
    Neurologist; 2007 Sep; 13(5):261-71. PubMed ID: 17848866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Limbic encephalitis--evolving concepts].
    Serratrice G; Pellissier JF; Serratrice J; De Paula A
    Bull Acad Natl Med; 2008 Nov; 192(8):1531-41; discussion 1541-2. PubMed ID: 19445370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbic encephalitis: an expanding concept.
    Graus F; Saiz A
    Neurology; 2008 Feb; 70(7):500-1. PubMed ID: 18268242
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis.
    Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar C; Martínez-Rodriguez JE; Vincent A; Santamaría J
    Ann Neurol; 2006 Jan; 59(1):178-81. PubMed ID: 16278841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of non-herpetic limbic encephalitis].
    Shoji H
    Brain Nerve; 2010 Aug; 62(8):853-60. PubMed ID: 20714033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome].
    Misawa T; Mizusawa H
    Brain Nerve; 2010 Apr; 62(4):339-45. PubMed ID: 20420173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies.
    Modoni A; Masciullo M; Spinelli P; Marra C; Tartaglione T; Andreetta F; Tonali P; Silvestri G
    Cogn Behav Neurol; 2009 Mar; 22(1):63-6. PubMed ID: 19372772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage-gated potassium channel antibodies in limbic encephalitis.
    Pozo-Rosich P; Clover L; Saiz A; Vincent A; Graus F
    Ann Neurol; 2003 Oct; 54(4):530-3. PubMed ID: 14520669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies.
    Pellkofer HL; Kuempfel T; Jacobson L; Vincent A; Derfuss T
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1407-8. PubMed ID: 20667865
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilomotor seizures and status in non-paraneoplastic limbic encephalitis.
    Wieser S; Kelemen A; Barsi P; Vincent A; Borbely C; Rasonyi G; Mueller S; Hess K; Wieser HG; Halasz P
    Epileptic Disord; 2005 Sep; 7(3):205-11. PubMed ID: 16162429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.